TP53 and inborn error of immunity: GSEA results indicated that numerous typical tumor-related signaling pathways were significantly enriched in ChRCC patients, such as oxidative phosphorylation, PPAR signaling pathway, Notch signaling pathway, P53 signaling pathway, and primary immunodeficiency (Supplementary file Figure 6).